CSP EXAM TEST (SPECIALTY PHARMACY) WITH 50+ QUESTIONS AND CORRECT
ANSWERS 2024
1. Which of the following are typically considered attributes of specialty drugs?
$%^&*()_+
A) High cost (at least over $660/month but usually higher)
B) Requires special storage and handling requirements
C) Must be administered via IV
D) Treats acute or chronic complex diseases
E) Requires additional patient education and counseling: A, B, D, and E
*for C, can be subq, IM, inhaled/infused, intravitreal/eye, or oral
2. Which task is typically associated with PV1?: comparing what is on the "hard copy" and
what has been typed
3. T/F: all entities are contractually engaged: true
4. T/F: all entities follow specific operational policies and procedures specific by contract:
true
5. T/F: the performance of all entities is measured and managed: true
6. T/F: all entities have financial incentives to act in a cost-efficient manner: -
True
7. T/F: pharmacy benefit managers are insurance and collect premiums from plan
sponsors: false
8. Drug distribution is ? Managed: not
9. Prescription management is ? Managed: aggressively
10. Supply chain: steps it takes to get a product or service from its original state to the
customer
*includes product development, marketing, operations, distribution, finance, and customer
service
11. Supply chain management: optimizing all steps in the supply chain to maximize
consumer value and obtain competitive edge
1/7
, CSP EXAM TEST (SPECIALTY PHARMACY) WITH 50+ QUESTIONS AND CORRECT
ANSWERS 2024
12. In 2015, drugs used to treat what disease state caused a dramatic spike in prescription
drug spend?: Hepatitis C
$%^&*()_+
13. Specialty pharmacy spend makes up between 40% and 50% of overall drug spend,
but specialty claims make up approximately what percent of all claims?: 2
14. Which two disease states experienced the highest absolute growth in specialty
pharmacy?: oncology and autoimmune disorders
15. Partial fill (split fill) programs are most commonly used for which disease state?:
oncology
16. T/F: biosimilars have been used in Europe for the last 10 years or so: true
17. T/F: biosimilars are readily available in the market for comparator products Humira and
Enbrel in the US: false
2/7
ANSWERS 2024
1. Which of the following are typically considered attributes of specialty drugs?
$%^&*()_+
A) High cost (at least over $660/month but usually higher)
B) Requires special storage and handling requirements
C) Must be administered via IV
D) Treats acute or chronic complex diseases
E) Requires additional patient education and counseling: A, B, D, and E
*for C, can be subq, IM, inhaled/infused, intravitreal/eye, or oral
2. Which task is typically associated with PV1?: comparing what is on the "hard copy" and
what has been typed
3. T/F: all entities are contractually engaged: true
4. T/F: all entities follow specific operational policies and procedures specific by contract:
true
5. T/F: the performance of all entities is measured and managed: true
6. T/F: all entities have financial incentives to act in a cost-efficient manner: -
True
7. T/F: pharmacy benefit managers are insurance and collect premiums from plan
sponsors: false
8. Drug distribution is ? Managed: not
9. Prescription management is ? Managed: aggressively
10. Supply chain: steps it takes to get a product or service from its original state to the
customer
*includes product development, marketing, operations, distribution, finance, and customer
service
11. Supply chain management: optimizing all steps in the supply chain to maximize
consumer value and obtain competitive edge
1/7
, CSP EXAM TEST (SPECIALTY PHARMACY) WITH 50+ QUESTIONS AND CORRECT
ANSWERS 2024
12. In 2015, drugs used to treat what disease state caused a dramatic spike in prescription
drug spend?: Hepatitis C
$%^&*()_+
13. Specialty pharmacy spend makes up between 40% and 50% of overall drug spend,
but specialty claims make up approximately what percent of all claims?: 2
14. Which two disease states experienced the highest absolute growth in specialty
pharmacy?: oncology and autoimmune disorders
15. Partial fill (split fill) programs are most commonly used for which disease state?:
oncology
16. T/F: biosimilars have been used in Europe for the last 10 years or so: true
17. T/F: biosimilars are readily available in the market for comparator products Humira and
Enbrel in the US: false
2/7
